JdM BIOCLIN
0502.663.007 · rovalta.com · 25/09/2026
JdM BIOCLIN
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOJdM BIOCLIN is a Private limited company incorporated in 2013. Its registered office is in Chaudfontaine.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0502.663.007
- Incorporation
- 22/01/2013
- Legal form
- Private limited company
- Registered office
- Avenue Louis Piedboeuf 13
4053 Chaudfontaine · WallonieSee on map - Contributed capital
- 12 400,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 13 filingsTrend over 13 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 332 k € | +9.7% | 302,8 k € | +3.1% | 293,8 k € | +7.5% | 273,4 k € | -36.8% | 432,8 k € |
| EBITDA | 330,9 k € | +9.5% | 302,3 k € | +3.1% | 293,1 k € | +7.7% | 272,2 k € | -36.9% | 431,6 k € |
| Operating result | 205,8 k € | -26.1% | 278,5 k € | +2.8% | 271 k € | +0.9% | 268,6 k € | -37.3% | 428,5 k € |
| Net result | 121 k € | -38.3% | 196,1 k € | -5.0% | 206,5 k € | +21.4% | 170,2 k € | -44.0% | 303,8 k € |
| Balance sheet | |||||||||
| Equity | 618,4 k € | -27.6% | 854 k € | +29.8% | 657,9 k € | +8.9% | 604,3 k € | +11.5% | 541,9 k € |
| Total assets | 851,7 k € | -10.9% | 956,4 k € | +2.6% | 932,2 k € | +25.5% | 742,8 k € | +0.1% | 741,8 k € |
| Cash | 179,8 k € | -51.7% | 372,3 k € | +23.0% | 302,7 k € | -3.2% | 312,6 k € | -38.0% | 504,3 k € |
| Debts | 130,6 k € | +28.2% | 101,9 k € | -62.8% | 273,8 k € | +98.4% | 138 k € | -30.9% | 199,8 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 4 ended
Active mandates
Ended mandates
Other companies at this address
Avenue Louis Piedboeuf 13 4053 Chaudfontaine| Company | CBE no. |
|---|---|
DOCTEUR SYLVIE LEPAGE● Active | 0627.904.952 |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 30/06/2026 | 10/07/2025 | 29/07/2024 | 28/07/2023 | 27/07/2022 | 29/07/2021 |
| General meeting | 19/06/2026 | 20/06/2025 | 28/06/2024 | 29/06/2023 | 22/06/2022 | 18/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 13 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 19/06/2026 | 30/06/2026 | French | |
| Micro model | 31/12/2024 | 20/06/2025 | 10/07/2025 | French | |
| Micro model | 31/12/2023 | 28/06/2024 | 29/07/2024 | French | |
| Micro model | 31/12/2022 | 29/06/2023 | 28/07/2023 | French | |
| Micro model | 31/12/2021 | 22/06/2022 | 27/07/2022 | French | |
| Micro model | 31/12/2020 | 18/06/2021 | 29/07/2021 | French | |
| Micro model | 31/12/2019 | 19/06/2020 | 31/07/2020 | French | |
| Micro model | 31/12/2018 | 28/06/2019 | 31/07/2019 | French | |
| Micro model | 31/12/2017 | 15/06/2018 | 01/08/2018 | French | |
| Micro model | 31/12/2016 | 16/06/2017 | 28/07/2017 | French | |
| Abridged model | 31/12/2015 | 29/06/2016 | 14/07/2016 | French | |
| Abridged model | 31/12/2014 | 19/06/2015 | 28/07/2015 | French | |
| Abridged model | 31/12/2013 | 20/06/2014 | 29/07/2014 | French |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 4 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official GazetteSimilar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 2025121 k €↓
- 2024Annual accounts 2024196,1 k €↓
- 2023Annual accounts 2023206,5 k €↑
- 2022Annual accounts 2022170,2 k €↓
- 2021Annual accounts 2021303,8 k €↑
- 2020Annual accounts 2020151 k €↑
- 2019Annual accounts 2019131,8 k €↑
- 2018Annual accounts 2018104 k €↓
- 2017Annual accounts 2017111,9 k €↑
- 2016Annual accounts 201695,1 k €↑
- 2015Annual accounts 201581,7 k €↓
- 2014Annual accounts 201490,6 k €↓
- 2013Annual accounts 2013106,5 k €
- 22/01/2013IncorporationPrivate limited company